ASP8825 - Study in Patients With Restless Legs Syndrome

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

NCT00389831 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome

NCT03345953 ·Status: TERMINATED ·Phase: PHASE2

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

NCT00498108 ·Status: COMPLETED ·Phase: PHASE3

Rotigotine Restless Legs Syndrome Dose Finding Trial

NCT00243217 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

NCT05234762 ·Status: UNKNOWN ·Phase: PHASE2

An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

NCT00263068 ·Status: COMPLETED ·Phase: PHASE3

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

NCT00498186 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT05039099 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Nitrazine in the Treatment of ALS

NCT04950647 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

NCT00530790 ·Status: COMPLETED ·Phase: PHASE2

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012 ·Status: COMPLETED ·Phase: PHASE4

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

NCT00051961 ·Status: COMPLETED

Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor

NCT04880616 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study

NCT06631300 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

NCT02025608 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

NCT00627003 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

NCT01562743 ·Status: COMPLETED ·Phase: PHASE2

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

NCT00152958 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

NCT03728933 ·Status: TERMINATED ·Phase: PHASE3

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

NCT01823770 ·Status: COMPLETED ·Phase: PHASE4

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

NCT00895232 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

NCT01332695 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

NCT01498120 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

NCT05923905 ·Status: RECRUITING ·Phase: PHASE4

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

NCT01521663 ·Status: COMPLETED ·Phase: PHASE2